During the past decade, JCHC McCreery Cancer Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JCHC McCreery Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 7 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JCHC McCreery Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "JCHC McCreery Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Breast Cancer" (2 trials), "Estrogen Receptor Negative" (2 trials) and "HER2/Neu Negative" (2 trials). Many other conditions were trialed in "JCHC McCreery Cancer Center" in a lesser frequency.

Most popular intervention types in "JCHC McCreery Cancer Center" are "Other" (19 trials), "Drug" (16 trials), "Biological" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Carboplatin" (3 trials), "Clinical Observation" (3 trials), "Crizotinib" (3 trials) and "Nivolumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "JCHC McCreery Cancer Center" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "JCHC McCreery Cancer Center". undefined are not yet recruiting, 3 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in JCHC McCreery Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in JCHC McCreery Cancer Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".